Shine-On BioMedical Co.,Ltd. (TPEX:6926)
Taiwan · Delayed Price · Currency is TWD 65.00
+0.20 (0.31%)
Jul 9, 2026, 10:20 AM CST
Shine-On BioMedical Market Cap
Shine-On BioMedical has a market cap or net worth of 3.24 billion as of July 9, 2026. Its market cap has decreased by -1.52% in one year.
Market Cap
3.24B
Enterprise Value
2.32B
Revenue
30.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
65.00
Market Cap Chart
Since November 25, 2022, Shine-On BioMedical's market cap has decreased from 3.83B to 3.24B, a decrease of -15.47%. That is a compound annual growth rate of -4.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 3.24B | -7.14% |
| Dec 31, 2025 | 3.49B | 2.79% |
| Dec 31, 2024 | 3.39B | -1.87% |
| Dec 29, 2023 | 3.46B | 9.81% |
| Dec 30, 2022 | 3.15B | -17.82% |
| Nov 25, 2022 | 3.83B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genovate Biotechnology | 3.79B |
| Formosa Pharmaceuticals | 3.68B |
| Sagittarius Life Science | 3.53B |
| SYN-TECH Chem. & Pharm. | 3.33B |
| BioGend Therapeutics | 3.27B |
| Energenesis Biomedical CO.,LTD. | 3.23B |
| Chunghwa Chemical Synthesis & Biotech | 3.04B |
| Apex Biotechnology | 3.02B |